Plant derived nanoparticles for malaria treatment
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Malaria is a mosquito-borne infectious disease that is caused by the Plasmodium parasite.
newlineMost of the available medication are losing their efficacy. Therefore, it is crucial to create
newlinefresh leads to combat malaria. Green silver nanoparticles (AgNPs) have recently attracted
newlinea lot of attention in biomedical research. As a result, green mediated AgNPs from leaves
newlineand bark of Terminalia bellirica and Prosopis juliflora, a medicinal plant with purported
newlineantimalarial effects, were used in this investigation. Initially, cysteine/methionine-rich
newlineproteins (M18 aspartyl aminopeptidase, Pf12p, and tyrosyl-tRNA synthetase) from
newlinePlasmodium species were studied computationally as potential therapeutic targets. Natural
newlinecompounds from the leaves and bark constituents (Rutin, and#946;-Glucogallin, Quercetin-3-Orutinoside,
newlineAstragalin Isorhamnetin-3-O-rutinoside, Bellericoside, Isorhamnetin-3-Oglucoside,
newlineLuteolin-7-O-glucoside, and and#946;-Glucogallin) of T. bellirica and P. juliflora were
newlineinteracted with the selected drug targets via hydrogen and hydrophobic bonds and the
newlinedocking scores between them was -9.93 to -11.25 kcal/mol. The green mediated silver
newlinenanoparticles were afterward produced using leaf extract and were further examined using
newlineUV-vis spectrophotometer, DLS, Zeta potential, FTIR, XRD, and FESEM. The size of
newlinegreen mediated AgNPs was validated by the FESEM results; the average size of TBLAgNPs
newlinewas around 44.05 nm. The zeta potential study also supported the green mediated
newlineAgNPs stability. Additionally, Plasmodium falciparum (3D7) cultures were used to assess
newlinethe antimalarial efficacy, and green mediated TBL-AgNPs and TBB-AgNPs could
newlineeffectively inhibit the parasitized red blood cells (pRBCs) as compared to PJL-AgNPs and
newlinePJB-AgNPs. In conclusion, this novel class of AgNPs may be used as a potential
newlinetherapeutic replacement for the treatment of malaria.
newline